BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Dow
US Army
Novartis
Harvard Business School
Daiichi Sankyo
Accenture
Julphar
US Department of Justice
Teva

Generated: January 17, 2018

DrugPatentWatch Database Preview

Deproco Company Profile

« Back to Dashboard

What is the competitive landscape for DEPROCO, and what generic and branded alternatives to DEPROCO drugs are available?

DEPROCO has six approved drugs.



Summary for Deproco
US Patents:0
Tradenames:5
Ingredients:4
NDAs:6

Drugs and US Patents for Deproco

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Deproco LIGNOSPAN FORTE epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088389-001 Jan 22, 1985 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Deproco SCANDONEST PLAIN mepivacaine hydrochloride INJECTABLE;INJECTION 088387-001 Oct 10, 1984 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Deproco LIGNOSPAN STANDARD epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088390-001 Jan 22, 1985 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Deproco SEPTOCAINE articaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 022010-001 Mar 30, 2006 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Deproco SEPTOCAINE articaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 020971-001 Apr 3, 2000 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Deproco SCANDONEST L levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 088388-001 Oct 10, 1984 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
US Army
McKinsey
Johnson and Johnson
McKesson
Express Scripts
Deloitte
Cantor Fitzgerald
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot